If you want a comprehensive app experience alongside your GLP-1 medication, youll like Noom
Medicare Part D patients continue to face prior authorization and cost-sharing barriers, even with a diabetes diagnosis 3

see the NHS orlistat page for eligibility and guidance), or GLP-1-based therapies such as semaglutide 2.4 mg (Wegovy), which has received MHRA approval and a NICE Technology Appraisal recommendation (NICE TA875) for use in adults with a BMI of 35 kg/m or above (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when used within a specialist weight management service Enquire about clinical trial eligibility , if you are interested in accessing investigational medicines through a regulated research pathway your GP or specialist can advise, and you can search for trials via the NIHR 'Be Part of Research' website or ClinicalTrials.gov Discuss realistic expectations , as even the most effective weight loss medicines work best alongside dietary changes, increased physical activity, and behavioural support Your GP can refer you to a specialist weight management service if appropriate

Those currently using CPAP should continue therapy during the initial months of tirzepatide treatment
Semaglutide injections reduce appetite by activating GLP-1 receptors in the brain, leading to an average weight loss of 15% of body weight in clinical trials